TITLE

Review: SSRIs are associated with increased risk for attempted or completed suicide in adolescents but not in adults or the elderly

AUTHOR(S)
Cheung, Amy
PUB. DATE
June 2009
SOURCE
ACP Journal Club;6/23/2009, Vol. 150 Issue 6, p11
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the risk of suicides in persons with depression who have used selective serotonin reuptake inhibitors (SSRI). It analyzes cohort studies that provided datum for completed or attempted suicide among depressed persons. The results showed that the use of SSRIs was associated with an increased risk for attempted or completed suicide in adolescents but not in adults or elderly persons.
ACCESSION #
42876703

 

Related Articles

  • Study backs GP ban on SSRIs.  // Pulse;11/9/2006, Vol. 66 Issue 42, p13 

    The article reports on the increased risk of suicidal behavior among young people who are taking selective serotonin reuptake inhibitors in Great Britain. According to a study conducted by Dr. Bernadka Duicka and her team, the suicidal rate has escalated by 70%. She recommended a single,...

  • Social anxiety disorder. Schneier, Franklin R. // BMJ: British Medical Journal (International Edition);9/6/2003, Vol. 327 Issue 7414, p515 

    Editorial. Comments on social anxiety disorder which is common, underdiagnosed, impairing and treatable. How the hallmark of the disorder prevents sufferers from seeking help until they have a complication such as alcoholism or major depression; Symptoms of the the disease; Established...

  • Suicide risk not increased with SSRI antidepressants. Ham, Peter // Journal of Family Practice;Aug2003, Vol. 52 Issue 8, p587 

    The article presents information on the relation between selective serotonin reuptake inhibitors (SSRI) antidepressants on suicide risk. The researchers observed that SSRI is effective in preventing suicidal action of depressed adult patients. It is found that there is a low suicide rate in the...

  • Efficacy of antidepressants in adults. Moncrieff, Joanna; Kirsch, Irving // BMJ: British Medical Journal (International Edition);7/16/2005, Vol. 331 Issue 7509, p155 

    Offers a debate regarding the efficacy of antidepressants in adults. Report that the National Institute for Health and Clinical Excellence (NICE) recommended that antidepressants, such as selective serotonin reuptake inhibitors, should be first line treatment for moderate or severe depression;...

  • Fluoxetine and Suicidal Behaviour: Some Clinical and Theoretical Aspects of a Controversy. Power, A. C.; Cowen, P. J. // British Journal of Psychiatry;Dec92, Vol. 161, p735 

    The article examines the controversy surrounding the association of fluoxetine and suicidal behavior. Some anecdotal accounts and clinical trials are discussed to determine the level of evidence supporting or opposing the link between fluoxetine and the emergence of suicidal ideation. The...

  • In comparison with other antidepressants, are SSRIs more likely to lead to suicide (or self-harm/suicide attempts) in adults? Summerton, Nick // Update;3/17/2005, Vol. 70 Issue 3, p14 

    This article focuses on various studies related to suicidal behavior. It has been suggested that some antidepressant drugs, in particular the SSRIs, may lead to the emergence or worsening of suicidal ideas in certain patients resulting in an increased incidence of suicide or suicide attempts....

  • Psychopharmacological Treatment of Major Depressive Disorder in Children and Adolescents. Varley, Christopher K. // JAMA: Journal of the American Medical Association;8/27/2003, Vol. 290 Issue 8, p1091 

    Editorial. Comments on the report by Wagner and colleagues which studied the psychopharmacological treatment of major depressive disorder (MDD) in children and adolescents. Report which constitutes the largest positive psychopharmacological study of MDD is this age group; Depression which is a...

  • Review: little evidence to support dose escalation of selective serotonin reuptake inhibitors in non-responders. Ruhé, H. G.; Huyser, J.; Swinkels, J. A. // Evidence Based Mental Health;May2007, Vol. 10 Issue 2, p46 

    The article presents a review of various researches on the efficacy of dose escalation of selective serotonin reuptake inhibitors (SSRI) for treating major depressive disorders. The studies were randomized controlled trials that assessed the effects of dose escalation of SSRIs for major...

  • Serum Prolactin and Macroprolactin Levels among Outpatients with Major Depressive Disorder Following the Administration of Selective Serotonin-Reuptake Inhibitors: A Cross-Sectional Pilot Study. Kim, Sollip; Park, Young-Min // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Clinical trials evaluating the rate of short-term selective serotonin-reuptake inhibitor (SSRI)-induced hyperprolactinemia have produced conflicting results. Thus, the aim of this study was to clarify whether SSRI therapy can induce hyperprolactinemia and macroprolactinemia. Fifty-five patients...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics